Gene: TM6SF2 ×
Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 53345
Gene Symbol: TM6SF2
TM6SF2 		0.060 AlteredExpression disease BEFREE We measured levels and patterns of TM6SF2 in liver biopsies from 73 patients with chronic hepatitis C, livers of HCV-infected humanized Alb-uPA/SCID/beige mice, and HCV-infected Huh7.5.1 cells. 30144428 2018
Entrez Id: 53345
Gene Symbol: TM6SF2
TM6SF2 		0.060 GeneticVariation disease BEFREE In conclusion, the TM6SF2 E167K variant promotes the development of steatosis, fibrosis and cirrhosis in patients with chronic hepatitis C. Conversely, this variant reduces circulating atherogenic lipid fractions. 28839198 2017
Entrez Id: 53345
Gene Symbol: TM6SF2
TM6SF2 		0.060 GeneticVariation disease BEFREE TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C. 26259026 2016
Entrez Id: 53345
Gene Symbol: TM6SF2
TM6SF2 		0.060 AlteredExpression disease BEFREE Serum inflammatory markers and hepatic expression of TM6SF2 and genes regulating lipid metabolism were assessed in a subset with chronic hepatitis C (CHC). 26822232 2016
Entrez Id: 53345
Gene Symbol: TM6SF2
TM6SF2 		0.060 GeneticVariation disease BEFREE This is the first demonstration that TM6SF2 E167K variant is an independent predictor of liver steatosis in chronic hepatitis C. 25581573 2015
Entrez Id: 53345
Gene Symbol: TM6SF2
TM6SF2 		0.060 GeneticVariation disease BEFREE Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients. 25820484 2015